Filgotinib
Filgotinib is a pharmaceutical drug with 41 clinical trials. Currently 11 active trials ongoing. Historical success rate of 73.1%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
14
Mid Stage
20
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
67.9%
19 of 28 finished
32.1%
9 ended early
11
trials recruiting
41
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
OLE Study With Filgotinib in JIA
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
Clinical Trials (41)
Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
OLE Study With Filgotinib in JIA
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease
A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission
Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 41